GL Pharm Tech Corp. (KOSDAQ:204840)

GL Pharm Tech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 20, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	82,202	84,606	75,097	70,834	46,578	76,699
Market Cap Growth	8.76%	12.66%	6.02%	52.08%	-39.27%	12.04%
Enterprise Value	97,899	99,657	82,885	82,845	55,794	82,225
Last Close Price	1060.00	1091.00	977.00	1136.00	750.00	1240.00
PE Ratio	6581.96	6774.45	-	-	-	-
PS Ratio	2.33	2.40	2.88	2.72	2.78	6.17
PB Ratio	4.13	4.25	3.82	5.77	2.90	4.39
P/TBV Ratio	4.24	4.36	3.98	6.18	3.10	4.92
EV/Sales Ratio	2.78	2.83	3.18	3.18	3.34	6.62
EV/EBITDA Ratio	63.18	78.44	-	-	-	-
EV/EBIT Ratio	178.79	371.20	-	-	-	-
Debt / Equity Ratio	0.94	0.94	0.75	1.45	0.86	0.45
Debt / EBITDA Ratio	14.75	14.75	-	-	-	-
Net Debt / Equity Ratio	0.79	0.79	0.53	1.11	0.58	0.10
Net Debt / EBITDA Ratio	12.36	12.36	-180.25	-12.52	-8.35	-2.53
Net Debt / FCF Ratio	-3.63	-3.63	-2.06	-3.15	-1.20	-0.47
Asset Turnover	0.77	0.77	0.63	0.65	0.46	0.37
Inventory Turnover	2.15	2.15	2.08	2.86	2.67	2.83
Quick Ratio	0.48	0.48	0.74	0.81	0.79	2.02
Current Ratio	1.01	1.01	1.37	1.35	1.24	2.73
Return on Equity (ROE)	0.06%	0.06%	-14.63%	-26.42%	-4.71%	-23.49%
Return on Assets (ROA)	0.37%	0.37%	-2.69%	-5.00%	-5.59%	-5.06%
Return on Invested Capital (ROIC)	0.13%	0.13%	-6.31%	-12.59%	-14.62%	-14.63%
Return on Capital Employed (ROCE)	1.00%	1.00%	-6.20%	-11.70%	-11.70%	-10.00%
Earnings Yield	0.02%	0.01%	-3.11%	-5.29%	-1.70%	-4.86%
FCF Yield	-5.26%	-5.11%	-6.71%	-6.13%	-16.55%	-4.69%
Buyback Yield / Dilution	-	-	-21.16%	-0.34%	-21.96%	-13.03%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.